| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 09/16/1999 | WO1999046300A1 Products comprising inactivated yeasts or moulds and active vhh-type antibodies |
| 09/16/1999 | WO1999046283A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | WO1999046277A1 HUMAN EDG-1c POLYNUCLEOTIDES AND POLYPEPTIDES AND METHODS OF USE |
| 09/16/1999 | WO1999045947A1 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 09/16/1999 | WO1998041531A3 Solvent for biopolymer synthesis, solvent microdroplets and methods of use |
| 09/16/1999 | WO1996012802A9 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/16/1999 | DE19810661A1 Preparation of a protein product from protein sources such as meat |
| 09/16/1999 | CA2588590A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/16/1999 | CA2321026A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 09/15/1999 | EP0941733A2 Methods of inhibiting leaderless protein export using cardiac glycosides and derivatives |
| 09/15/1999 | EP0941346A1 Secretory immunoglobulin a as a mucosal vaccine delivery system |
| 09/15/1999 | EP0941105A1 Pretraumatic use of hemoglobin |
| 09/15/1999 | EP0941104A1 Peptide synthesis with sulfonyl protecting groups |
| 09/15/1999 | EP0832098A4 Method of producing igf-i and igfbp-3 with correct folding and disulfide bonding |
| 09/15/1999 | CN1228769A Process for preparing amidines |
| 09/15/1999 | CN1228439A Bacterial pilli purification technology |
| 09/15/1999 | CN1228438A Sericin polypeptide extracted from frison, husks and waste silk and its extracting method |
| 09/14/1999 | US5952497 N.sup.α -Bpoc amino acid pentafluorophenyl (Pfp) esters and 3,4-dihydro-4-oxo-1,2,3-benzotriazin-3-yl (ODhbt) esters |
| 09/14/1999 | US5952492 Reacting a mixture of diacid with dimethyl pimelate, hydrochloric acid, methanol, dibutyl ether to form intermediate, adding o-benzyl hydroxylamine hydrochloride and triethylamine, additing di-tert-butyl dicarbonate |
| 09/14/1999 | US5952470 Method for separating unmodified hemoglobin from cross-linked hemoglobin |
| 09/14/1999 | US5952465 Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site |
| 09/14/1999 | US5952461 Process for preparing human proinsulin |
| 09/14/1999 | US5952299 Cyclic peptide nuclei and derivatives thereof |
| 09/14/1999 | US5952034 Increasing the digestibility of food proteins by thioredoxin reduction |
| 09/14/1999 | US5951974 At least about 15%, preferably about 30%, of the interferon conjugates have a nonantigenic alkylpolyether attached to a preferential histidine residue; high activity; reacting an n-oxycarbonyloxyimide at acidic ph |
| 09/14/1999 | CA2086087C Growth hormone crystals and a process for production of these gh-crystals |
| 09/14/1999 | CA1340742C Process for chromatographically separating plasma proteins, protein concentrates produced, particularly factor viii, fibrinogene, von willebrand factor and fibronectin |
| 09/14/1999 | CA1340735C Htlv-iii envelope peptides |
| 09/10/1999 | WO1999045394A1 Improved method for purifying cholera toxin |
| 09/10/1999 | WO1999045026A1 Method for increasing the serum half-life of a biologically active molecule |
| 09/10/1999 | WO1999044741A1 Reaction block docking station |
| 09/10/1999 | WO1999032428A3 Synthesis of diamines |
| 09/10/1999 | CA2322846A1 Improved method for purifying cholera toxin |
| 09/10/1999 | CA2291767A1 Reaction block docking station |
| 09/08/1999 | EP0939835A1 Compositions and methods for treating viral infections |
| 09/08/1999 | EP0939766A2 Synthesis of soluble beta-sheet forming peptides |
| 09/08/1999 | EP0939643A1 Immunomodulating compounds comprising d-isomers of amino acids |
| 09/08/1999 | EP0806979B1 Gradient density filter |
| 09/08/1999 | EP0637968B1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING |
| 09/08/1999 | EP0353250B1 The engineering of electrostatic interactions at metal ion binding sites for the stabilization of proteins |
| 09/08/1999 | EP0138855B2 Method of determining antigenically active amino acid sequences |
| 09/08/1999 | CN1227846A Process for producing hydrophobic polypeptides, proteins or peptides |
| 09/07/1999 | US5948895 Process for producing a glycosylated amino compound |
| 09/07/1999 | US5948894 Immunoadsorbent reagents |
| 09/07/1999 | US5948887 Polypeptides that include conformation-constraining groups which flank a protein--protein interaction site |
| 09/07/1999 | US5948696 Combinatorial biaryl amino acid amide libraries |
| 09/07/1999 | US5948693 Solid phase synthesis of immunosuppressive agents |
| 09/07/1999 | US5948624 Methods for the detection and isolation of biomolecules |
| 09/07/1999 | US5948410 Animal cell culture |
| 09/07/1999 | CA2138765C Recombinant haemophilus influenzae protein and nucleotide sequence encoding same |
| 09/07/1999 | CA1340726C Redox amino acids and peptides containing them |
| 09/02/1999 | WO1999043712A1 Method for producing a factor viii/von willebrand factor complex |
| 09/02/1999 | WO1999043338A1 Antibacterial drugs, methods for their design and methods for their use |
| 09/02/1999 | WO1999029814A3 Method of preparing lipoproteins, lipoaminoacids, lipid esters, and glucolipids from olive oil and/or its constituents which are condensed with vegetal protein hydrolysates or aminoacids or esterificated with fatty alcohols or sugars |
| 09/02/1999 | CA2321946A1 Methods and compositions using tumor specific soluble interleukin-2 receptor alpha molecules |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939121A2 TNF-binding proteins |
| 09/01/1999 | EP0939085A1 A process for the purification of a motility-promoting protein from buffalo serum |
| 09/01/1999 | EP0938585A1 Detection and quantitation of endotoxin by fluorescence polarization |
| 09/01/1999 | EP0938549A1 Polymer-protein composites and methods for their preparation and use |
| 09/01/1999 | EP0938502A1 Selective acylation method |
| 09/01/1999 | EP0938501A1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 09/01/1999 | EP0938365A1 Shear separation method and system |
| 09/01/1999 | EP0828497B1 Methods of inhibiting leaderless protein export using cardiac glycosides or aglycones therefrom and derivatives |
| 09/01/1999 | EP0815121A4 Modified-affinity streptavidin |
| 09/01/1999 | EP0736035A4 Pretargeting methods and compounds |
| 09/01/1999 | EP0625160B1 Leukinferon preparation |
| 08/31/1999 | US5945543 Reacting corresponding free acids with primary or secondary amines in the presence of anhydrides of an alkanephosphonic acid |
| 08/31/1999 | US5945520 Chromatographic resins and methods for using same |
| 08/31/1999 | US5945515 Product and process for isolating DNA, RNA and proteins |
| 08/31/1999 | US5945274 Quantitative analysis of free lysylpyridinoline in a urine sample and correlating it to bone resorption in vivo wherein urine sample is hydrolyzed |
| 08/31/1999 | CA2183315C Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/31/1999 | CA2183314C Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 08/26/1999 | WO1999042605A1 One dimensional chemical compound arrays and methods for assaying them |
| 08/26/1999 | WO1999042487A1 Process for concentrating protein with disease-related conformation |
| 08/26/1999 | WO1999042486A1 Method of producing mouse and human endostatin |
| 08/26/1999 | WO1999042474A2 Method for designing dna-binding proteins of the zinc-finger class |
| 08/26/1999 | WO1999042193A1 Adsorption chromatography |
| 08/26/1999 | WO1999042130A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | WO1999042121A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | DE19810998C1 New metal-containing ribonucleotide proteins with nuclease and phosphatase activities, used e.g. for cell-selective inhibition of protein synthesis and inhibition of tumors |
| 08/26/1999 | CA2337638A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | CA2322048A1 Adsorption chromatography |
| 08/26/1999 | CA2321973A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | CA2321958A1 Method of producing mouse and human endostatin |
| 08/26/1999 | CA2321111A1 One-dimensional compound arrays and a method for assaying them |
| 08/26/1999 | CA2321101A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | CA2321088A1 Method for designing dna-binding proteins of the zinc-finger class |
| 08/26/1999 | CA2318473A1 Process for concentrating protein with disease-related conformation |
| 08/25/1999 | EP0938055A2 Discrete quantitative structure activity relationships |
| 08/25/1999 | EP0937735A1 A method for the removal of causative agent(s) of transmissible spongiform encephalopathies from protein solutions |
| 08/25/1999 | EP0937259A1 Process for the extraction of proteins |
| 08/25/1999 | EP0937253A1 Identification of drugs using complementary combinatorial libraries |
| 08/25/1999 | EP0781436A4 System and method of automatically generating chemical compounds with desired properties |
| 08/25/1999 | CN1226559A Method for extracting active materials containing proteins and peptides from five-age living silkworm |
| 08/24/1999 | US5942601 Peptide synthesis with sulfonyl protecting groups |
| 08/24/1999 | US5942547 2-Deoxystreptamine derivatives, pharmaceutical compositions thereof and therapeutic methods using same |
| 08/24/1999 | US5942463 Alkali resistant protein adsorbent |
| 08/24/1999 | US5942444 Marking of products to establish identity, source and fate |